Search
Toggle theme
Menu
Back
Home
Publications
Phase II study of single-agent arsenic trioxide for the front-line therapy of acute promyelocytic leukemia.
Public
More options
Phase II study of single-agent arsenic trioxide for the front-line therapy of acute promyelocytic leukemia.
N
Shared by
NobleBlocks
on Jul 10, 2011 • 12:00 AM UTC
Authors:
A. Ghavamzadeh
,
K. Alimoghaddam
,
S. Rostami
+6 more
Download PDF
Share
Summary
Sum
PDF
Figures
Figs
Discrepancies
Disc
EDDII
Article
Art
Subject
Medicine
Finding related papers...
Discussions
(0)
Add Comment
No comments yet
Be the first to share your thoughts!
Phase II study of single-agent arsenic trioxide for the front-line therapy of acute promyelocytic leukemia. | NobleBlocks
